869365-97-9

Basic information

• Product Name: (5-CHLORO-2-IODOPHENYL) 2,6-DIFLUOROPHENYL METHANO
• Synonyms: (5-CHLORO-2-IODOPHENYL) 2,6-DIFLUOROPHENYL METHANO
• CAS NO: 869365-97-9
• Molecular Formula: C₁₃H₆ClF₂IO
• Molecular Weight: 378.55
• Product Categories: API intermediates
• Mol File: 869365-97-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 433.54 °C at 760 mmHg
• Flash Point: 215.998 °C
• Appearance: /
• Density: 1.802±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.621
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: (5-CHLORO-2-IODOPHENYL) 2,6-DIFLUOROPHENYL METHANO(CAS DataBase Reference)
• NIST Chemistry Reference: (5-CHLORO-2-IODOPHENYL) 2,6-DIFLUOROPHENYL METHANO(869365-97-9)
• EPA Substance Registry System: (5-CHLORO-2-IODOPHENYL) 2,6-DIFLUOROPHENYL METHANO(869365-97-9)

Safety Data

• Hazardous Substances Data: 869365-97-9(Hazardous Substances Data)

Usage

General Description

(5-CHLORO-2-IODOPHENYL) 2,6-DIFLUOROPHENYL METHANO is a chemical compound that consists of a 5-chloro-2-iodophenyl group and a 2,6-difluorophenyl group attached to a methano bridge. It is a synthetic chemical that is used in pharmaceutical research and drug development. (5-CHLORO-2-IODOPHENYL) 2,6-DIFLUOROPHENYL METHANO may have potential applications in the field of medicinal chemistry, particularly in the development of new drugs for the treatment of various diseases and medical conditions. The specific properties and potential uses of this compound would need to be further studied and evaluated in a laboratory setting.

InChI:InChI=1/C13H6ClF2IO/c14-7-4-5-11(17)8(6-7)13(18)12-9(15)2-1-3-10(12)16/h1-6H

Upstream product

• 18063-02-0 2,6-difluorobenzoylchloride 
• 18437-66-6 N-(t-butoxycarbonyl)-4-chloroaniline 
• 869365-92-4 tert-butyl (4-chloro-2-(2,6-difluorobenzoyl)phenyl)carbamate 
• 28910-83-0 (2-amino-5-chlorophenyl)-(2,6-difluorophenyl)methanone 

Downstream Products

• 869363-13-3 4-{[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid 
• 869366-09-6 8-chloro-1-(2,6-difluorophenyl)-3,4-dihydrobenzo[c]azepin-5-one 
• 1393381-45-7 tert-butyl (1-(2-(4-((9-chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)benzamido)ethyl)piperidin-4-yl)carbamate 
• 1393381-46-8 N-(2-(4-aminopiperidin-1-yl)ethyl)-4-((9-chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)benzamide 
• 1233025-91-6 (5-chloro-2-iodophenyl)(2-fluoro-6-methoxyphenyl)methanone 
• 869366-03-0 tert-butyl (3-(4-chloro-2-(2,6-difluorobenzoyl)phenyl)prop-2-yn-1-yl)carbamate 
• 869366-10-9 8-chloro-4-[(dimethylamino)methylene]-1-(2,6-difluorophenyl)-3,4-dihydro-5H-2-benzazepin-5-one 
• 1028486-06-7 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate sodium salt 
• 869367-33-9 8-chloro-4-[(dimethylamino)methylene]-1-(2-fluoro-6-methoxyphenyl)-3,4-dihydro-5H-2-benzazepin-5-one 
• 1028486-01-2 alisertib 
• 869366-70-1 tert-butyl {3-[4-chloro-2-(2-fluoro-6-methoxybenzoyl)phenyl]prop-2-yn-1-yl}carbamate 

Relevant articles and documents

Small molecule with Aurora kinase degradation activity, preparation method and application thereof

The invention discloses a small molecule with Aurora kinase degradation activity, a preparation method and application thereof. According to the invention, 12 Aurora-A protein degradation agents basedon a PROTAC technology are obtained by using three E3 u

Bioorthogonal imaging of Aurora Kinase A in live cells

In living color: Aurora kinase A (AKA) was imaged in live cells using a bioorthogonal two-step reaction with a small molecule AKA inhibitor (see scheme) and a fluorescent reporter. The fluorescent molecule was localized to spindle poles and microtubules d

Compounds and methods for inhibiting mitotic progression

This invention relates to compounds and methods for the treatment of cancer. In particular, the invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising the compounds, and methods of using the compounds for the treat